Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuan Mei

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|February 6, 2025
Engineered Living Systems Based on Gelatin: Design, Manufacturing, and ApplicationsZhenwu Wang, Zeng Lin, Xuan Mei, et al.
Investigative and Clinical Urology|January 10, 2024
<i>COL6A1</i> expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtypeKyeong Kim, Young Joon Byun, Chuang-Ming Zheng, et al.
International Journal of Molecular Sciences|December 10, 2021
Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer ProgressionXuan-Mei Piao, Chaelin You, Young Joon Byun, et al.
Circulation|August 26, 2024
Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial InfarctionJunlang Li, Shenghuan Sun, Dashuai Zhu, et al.
International Journal of Molecular Sciences|October 26, 2024
Differential Urinary Microbiome and Its Metabolic Footprint in Bladder Cancer Patients Following BCG TreatmentKyungchan Min, Chuang-Ming Zheng, Sujeong Kim, et al.
International Journal of Molecular Sciences|November 26, 2022
Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk GroupsXuan-Mei Piao, Seon-Kyu Kim, Young Joon Byun, et al.
Urologic Oncology|November 18, 2018
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuriaYanjie Xu, Ye-Hwan Kim, Pildu Jeong, et al.
Cell Biomaterials|December 15, 2025
Immunomodulatory Microneedle Patch for Cardiac Repair in Rodent and Porcine Models of Myocardial InfarctionKe Huang, Dashuai Zhu, Jennifer Soto, et al.
Investigative and Clinical Urology|March 4, 2022
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zoneHo Won Kang, Young Joon Byun, Sung Min Moon, et al.
Cancer Genetics|November 11, 2022
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissuesChuang-Ming Zheng, Xuan-Mei Piao, Young Joon Byun, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Advanced Materials (Deerfield Beach, Fla.)|February 6, 2025
Engineered Living Systems Based on Gelatin: Design, Manufacturing, and ApplicationsZhenwu Wang, Zeng Lin, Xuan Mei, et al.
Investigative and Clinical Urology|January 10, 2024
<i>COL6A1</i> expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtypeKyeong Kim, Young Joon Byun, Chuang-Ming Zheng, et al.
International Journal of Molecular Sciences|December 10, 2021
Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer ProgressionXuan-Mei Piao, Chaelin You, Young Joon Byun, et al.
Circulation|August 26, 2024
Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial InfarctionJunlang Li, Shenghuan Sun, Dashuai Zhu, et al.
International Journal of Molecular Sciences|October 26, 2024
Differential Urinary Microbiome and Its Metabolic Footprint in Bladder Cancer Patients Following BCG TreatmentKyungchan Min, Chuang-Ming Zheng, Sujeong Kim, et al.
International Journal of Molecular Sciences|November 26, 2022
Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk GroupsXuan-Mei Piao, Seon-Kyu Kim, Young Joon Byun, et al.
Urologic Oncology|November 18, 2018
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuriaYanjie Xu, Ye-Hwan Kim, Pildu Jeong, et al.
Cell Biomaterials|December 15, 2025
Immunomodulatory Microneedle Patch for Cardiac Repair in Rodent and Porcine Models of Myocardial InfarctionKe Huang, Dashuai Zhu, Jennifer Soto, et al.
Investigative and Clinical Urology|March 4, 2022
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zoneHo Won Kang, Young Joon Byun, Sung Min Moon, et al.
Cancer Genetics|November 11, 2022
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissuesChuang-Ming Zheng, Xuan-Mei Piao, Young Joon Byun, et al.
Pageof 11